HBEGF and type 1 diabetes mellitus: Here we demonstrate that eGF triple therapy significantly improves measurements both re-epithelialization and granulation tissue in the NOD mouse model of T1D, and that addition of HB-EGF-PlGF-2123–144 to the regimen is indeed beneficial (Fig. 1).